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ABSTRACT
Rho small GTPases control multiple aspects of neuronal morphogenesis by 
regulating the assembly and organization of the actin cytoskeleton. Although they are 
negatively regulated by GTPase activating proteins (GAPs), the roles of RhoGAPs in 
the nervous system have not been fully investigated. Here we describe a charac-
terization of Drosophila RhoGAP68F that is mainly expressed in the embryonic central 
nervous system. RNA in situ hybridization analysis showed that expression of 
RhoGAP68F is highly restricted to the embryonic brain and ventral nerve cord. Data-
base search revealed that RhoGAP68F contains an N-terminal Sec14 domain and a 
C-terminal RhoGAP domain. Rho-GTP pull-down assay demonstrated that the RhoGAP 
domain of RhoGAP68F inactivates RhoA but not Rac1 or Cdc42 in HEK293 cells. In 
addition, expression of RhoGAP68F in NIH3T3 cells suppressed LPA-induced stress 
fiber formation, which is mediated by RhoA. Finally, neuronal overexpression of 
RhoGAP68F causes synaptic overgrowth at the larval neuromuscular junction (NMJ). 
Taken together, these results suggest that RhoGAP68F may play a role in synaptic 
growth regulation by inactivating RhoA. 
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INTRODUCTION
    Rho  small  GTPases  including  RhoA,  Rac1,  and 
Cdc42 regulate multiple aspects of neuronal develop-
ment  including  cell  migration,  cell  polarity,  axon 
growth  and  pathfinding,  and  dendritic  elaboration 
(Luo,  2000;  Govek  et  al.,  2005).  They  function  as 
molecular  switches  that  shift  between  an  active 
GTP-bound  state  and  an  inactive  GDP-bound  state 
(Jaffe  and  Hall,  2005).  The  active  forms  of  Rho 
small GTPases bind their specific effector molecules 
to  regulate  F-actin  and  microtubule  dynamics  and 
gene expression  (Jaffe  and  Hall,  2005).  While  gua-
nine  nucleotide  exchange  factors  (GEFs)  function 
as  positive  regulators  of  Rho  small  GTPases  by 
stimulating  the  exchange  of  bound  GDP  for  GTP, 
GTPase  activating  proteins  (GAPs)  negatively 
regulate  Rho  small  GTPases  by  enhancing  the 
intrinsic  GTPase  activity  of  Rho  proteins  (Luo, 
2000;  Moon  and  Zheng,  2003;  Jaffe  and  Hall, 
2005). 
    As  suggested  by  the  defined  roles  of  Rho 
GTPases in the nervous system, various Drosophila 
RhoGAP proteins have been implicated in neuronal 
morphogenesis.  For  example,  p190  RhoGAP  has 
been  shown  to  maintain  axon  branch  stability  in 30 Minyeop  Nahm  and  Seungbok  Lee
mushroom  body  neurons  by  inactivating  RhoA 
(Billuart  et  al.,  2001).  In  addition,  genetic  and 
biochemical  interaction  experiments  suggest  that 
CrossGAP/Vilse  mediates  Robo-mediated  axon 
repulsion by the local inactivation of Rac (Lundstrom 
et al., 2004; Hu et al., 2005). Recently, the Cdc42- 
selective  GAP  dRich  has  been  shown  to  promote 
synaptic  growth  at  the  neuromuscular  junction 
(NMJ)  (Nahm  et  al.,  2010),  further  demonstrating 
the  significance  of  RhoGAP  in  neuronal  develop-
ment. 
    Although the Drosophila genome contains at least 
20  predicted  RhoGAPs  (Hu  et  al.,  2005),  many  of 
them  have  not  been  characterized  in  the  nervous 
system.  In  this  study,  we  identified  RhoGAP68F  as 
a  RhoA-selective  GAP  that  is  highly  expressed  in 
the  embryonic  central  nervous  system  (CNS).  In 
addition, we show that overexpression of RhoGAP68F 
in motor neurons causes synaptic overgrowth at the 
larval  NMJ.  These  results  raise  the  possibility  that 
RhoGAP68F  may  play  an  essential  role  for  neu-
ronal  development  by  inactivating  RhoA.
MATERIALS  AND  METHODS
Cell  culture 
    HEK293  and  NIH3T3  cells  were  cultured  in 
Dulbecco's  modified  Eagle's  medium  (DMEM) 
containing  10%  fetal  bovine  serum  and  antibiotics. 
These  cells  were  transfected  using  Lipofectamine 
2000  (Invitrogen)  according  to  the  manufacturer's 
instructions.  To  induce  actin  structural  changes, 
NIH3T3  cells  were  serum-starved  for  12  hr  and 
treated  for  10  min  with  20  ng/ml  lysophosphatidic 
acid  (LPA)  (Sigma),  10  ng/ml  PDGF  (Upstate  Bio-
technology), or 100 ng/ml Bradykinin (Sigma) before 
fixation.
Plasmids
    The  full-length  cDNA  clone  for  RhoGAP68F  was 
obtained  from  the  Drosophila  Genomics  Resource 
Center.  The  entire  coding  region  of  RhoGAP68F 
was  amplified  by  PCR  using  appropriate  primers 
and  introduced  into  pcDNA-HA  (Invitrogen)  for 
mammalian  expression.  The  RhoGAP68F-  R315A  point 
mutation  was made  using the  QuikChange Multi  kit 
(Stratagene).  Plasmids  for  Myc-  RhoA,  Rac1,  and 
Cdc42  were  previously  described  (Nahm  et  al., 
2006). 
RNA  in  situ  hybridization
  R N A  in situ hybridization on whole mount embryos 
was  performed  as  previously  described  (Tautz  and 
Pfeifle,  1989).  The  entire  RhoGAP68F  cDNA  was 
cloned  into  pBluscript  (Stratagene).  The  resulting 
plasmid was linearized and used for the generation 
of  a  digoxygenin  (DIG)-UTP-labeled  RhoGAP68F 
RNA  probe  by  run-off  transcription.  Embryos  were 
dechorionated  and  fixed  in  PBS  containing  5% 
formaldehyde.  Fixed  embryos  were  hybridized  with 
DIG-labeled  riboprobes  at 62
oC  and then  incubated 
with  alkaline  phosphatase-conjugated  anti-DIG  anti-
body  for  1  hr  at  room  temperature.  The  alkaline 
phosphatase reaction was performed using 5-bromo- 
4-chloro-indoyl  phosphate  (BCIP)  and  nitro  blue 
tetrazolium  (NBT).  The  embryos  were  mounted  in 
Permount  (Fisher  Scientific).
Rho-GTP  pull-down  assay
    Inactivation  of  Rho  proteins  by  RhoGAP68F  was 
analyzed  using  the  EZ-detect  Rho,  Rac,  or  Cdc42 
activation  kit  (Pierce),  as  previously  described 
(Nahm et al., 2006). Briefly, HEK293 cells transiently 
expressing  pCMV-Myc-RhoA,  Rac1,  or  Cdc42  and 
pcDNA-HA-RhoGAP68F or pcDNA-HA-RhoGAP68F- 
R315A were lysed in 25 mM Tris (pH 7.5), 150 mM 
NaCl, 5 mM MgCl2, 1% NP-40, 1 mM DTT, and 5% 
glycerol. Cell lysates were clarified by centrifugation 
at  13,000×  g  for  10  min.  Equal  volumes  of  lysates 
were  then  incubated  at  4
oC  for  1  hr  with  gluta-
thione-Sepharose 4B-bound GST-Rhotekin-PBD (for 
RhoA-GTP)  or  GST-PAK1-PBD  (for  Rac1-GTP  and 
Cdc42-GTP) fusion protein. The beads were washed 
four  times  with  the  lysis  buffer  and  boiled  in  SDS 
sample buffer. The amount of GTP-bound Myc-RhoA, 
Rac1, or Cdc42 was determined by western blotting 
using  an  anti-Myc  antibody  (Cell  Signaling).  The 
total  amounts  of  Rho  proteins  from  cell  lysates 
were  determined  by  western  blotting  using  an  anti- 
Myc  or  anti-HA  (Roche)  antibody.
Fly  stock  and  genetics
    The wild-type strain used in this study was w
1118. 
A  transgenic  line  carrying  UAS-RhoGAP68F w a s  
obtained  in  the  w
1118  background  using  standard 
protocols (Robertson et al., 1988). Elav-GeneSwitch- RhoGAP68F  is  a  Neuronal  GAP  for  RhoA 31
Fig.  1.  Expression  of  RhoGAP68F  transcript  during  embryo  de-
velopment.  In  situ  hybridization  on  whole-mount  embryos  was 
performed  to  using  RhoGAP68F  antisense  RNA  probe.  All 
embryos  are  anterior  to  the  left,  and  dorsal  is  up.  (A)  Lateral 
v i e w  o f  a  s t a g e  5  e m b r y o .  RhoGAP68F  mRNA  was  broadly 
detected  throughout  the  entire  embryo,  indicating  its  maternal 
l o a d i n g .  ( B )  L a t e r a l  v i e w  o f  a  s t a g e  1 3  e m b r y o .  RhoGAP68F 
mRNA was abundant in the developing CNS. (C) Lateral view of 
a stage 16 embryo. High levels of RhoGAP68F expression were 
maintained in the CNS. (D) Lateral view of a stage 16 embryo. A 
RhoGAP68F  sense  probe  shows  no  signal.  Scale  bar,  20  μm.
GAL4  (Osterwalder  et  al.,  2001)  was  used  to  drive 
UAS-RhoGAP68F expression in postembryonic neu-
rons.
Immunohistochemistry
    NIH3T3  cells  were  transfected  with  a  plasmid 
encoding  HA-RhoGAP68F  or  HA-RhoGAP68F-R315A. 
Immunostaining  of  transfected  cells  was  performed 
as  previously  described  (Nahm  et  al.,  2006).  Fila-
mentous  actin  structures  were  visualized  using 
rhodamine-conjugated phalloidin (Invitrogen) at 1：250.
    Larval  body  wall  muscles  were  dissected  from 
wandering  third-instar  larvae  in  Ca
2＋-free  HL3 
saline  (Stewart  et  al.,  1994)  and  fixed  in  4%  for-
maldehyde in PBS for 30 min. Fixed muscles were 
washed  with  PBT  (PBS,  0.1%  Triton  X-100)  and 
incubated  with  goat  anti-HRP  conjugated  with  FITC 
(Jackson ImmunoResearch, 1：200) for 1 hr at room 
temperature.  Image  acquisition  and  morphological 
quantification were performed as previously described 
(Nahm  et  al.,  2010).
RESULTS  AND  DISCUSSION
Identification  of  RhoGAP68F,  a  RhoA-specific 
GAP  that  is  highly  expressed  in  the  nervous 
system   
    The  Drosophila  genome  contains  at  least  20 
RhoGAPs  for  the  Rho  family  (Hu  et  al.,  2005); 
however,  their  role(s)  in  the  developing  nervous 
system are still poorly understood. As an initial step 
to  address  this  issue,  we  searched  by  RNA  in  situ 
hybridization on whole-mount embryos for previously 
uncharacterized  RhoGAP  genes  expressed  in  the 
central  nerves  system  (CNS),  and  found  that  the 
annotated  gene  RhoGAP68F  (CG6811)  fulfills  the 
criterion. A high level of RhoGAP68F message was 
uniformly  detected  in  early  stage  embryos  (e.g. 
stage  5;  Fig.  1A),  suggesting  a  significant  maternal 
contribution  (Fig.  1A).  RhoGAP68F  expression  was 
restricted  to  brain  lobes  and  the  ventral  nerve  cord 
by stage 13 (Fig. 1B). The enrichment of RhoGAP68F 
expression  in  the  embryonic  CNS  was  maintained 
until  the  end  of  embryogenesis  (Fig.  1C). 
    The  Flybase  database  predicts  that  RhoGAP68F 
encodes  a  476-amino  acid  protein  consisting  of  an 
N-terminal Sec14 domain (amino acids 95-241) and 
a  C-terminal  RhoGAP  domain  (amino  acids  289- 
461).  This  domain  organization  is  identical  to  the 
human  p50RhoGAP  protein  (Fig.  2A).  Overall,  the 
RhoGAP68F protein displays 37% identity and 60% 
similarity to its human counterpart at the amino acid 
level. A previous work has shown that RhoGAP68F 
has  GAP  activity  toward  human  RhoA  in  vitro 
(Sanny  et  al.,  2006).  To  examine  the  in  vivo 
substrate  of  the  RhoGAP68F,  HEK293  cells  were 
transiently  transfected  with  pCMV-Myc-RhoA,  Rac1, 
or  Cdc42  along  with  either  pcDNA-HA  or  pcDNA- 
HA-RhoGAP68F,  and  the  amounts  of  active,  GTP- 
bound  Rho  GTPases  in  the  lysates  of  the  trans-
fectants  were  determined  by  p21-binding  domain 
(PBD) pull-down assays (see Materials and Methods). 
As shown in Fig. 2B, expression of HA-RhoGAP68F 
efficiently  removed  GTP-RhoA  (Fig.  2B).  However, 
the  level  of  GTP-Rac1  or  GTP-Cdc42  was  not 
changed  by  HA-RhoGAP68F  expression  (Fig.  2B), 
suggesting  that  RhoGAP68F  acts  as  a  RhoA- 
selective  GAP  in  vivo.  RhoGAP68F  contains  the 
arginine  finger  at  position  315,  which  is  conserved 
in  RhoGAP-family  proteins.  A  RhoGAP68F  mutant 
carrying  a  substitution  mutation  of  this  amino  acid 
(RhoGAP68F-R315A)  did  not  effectively  reduce  the 
level  of  GTP-RhoA  (Fig.  2B). 
RhoGAP68F  inhibits  LPA-induced  stress  fiber 
formation  mediated  by  RhoA
    Rho  small  GTPases  are  well  known  for  their 32 Minyeop  Nahm  and  Seungbok  Lee
Fig.  2.  RhoGAP68F  is  a  RhoA-selective  GAP.  (A) 
Domain  structure  of  RhoGAP68F  and  human 
p50RhoGAP.  The  percent  amino  acid  identity  be-
tween  the  homologs  is  indicated.  The  point  muta-
tion  R315A  in  the  GAP  domain  of  RhoGAP68F  is 
marked  by  asterisk.  (B)  RhoGAP68F  inactivates 
RhoA  but  not  Rac1  or  Cdc42  in  cells.  HEK293 
cells were co- transfected with a plasmid encoding 
Myc-RhoA,  Rac1,  or  Cdc42  along  with  a  plasmid 
encoding  HA,  HA-RhoGAP68F,  or  HA-RhoGAP68F- 
R315A.  Following  transfection,  GTP-loaded  RhoA, 
Rac1, and Cdc42 were precipitated with GST fusion 
P BD s o f Rho teki n (for Rh oA ) and  PA K 1 (for Ra c1 
and Cdc42). The levels of GTP-bound GTPases in 
the  precipitates  were  determined  by  western  blot 
analysis  using  an  anti-Myc  antibody  (upper  panel). 
Levels  of  HA  and  Myc  proteins  in  the  cell  lysates 
were  determined  by  western  blot  analysis  using 
anti-HA  (middle  panel)  and  anti-Myc  (lower  panel) 
antibodies,  respectively. 
Fig.  3.  Effect  of  RhoGAP68F  on  actin  cytoskeletal  changes 
induced by LPA, PDGF, and Bradykinin in NIH3T3 cells. NIH3T3 
cells  were  transfected  with  a  plasmid  expressing  either  HA- 
RhoGAP68F  (A)  or  HA-RhoGAP68F-R315A  (B).  After  a  12  hr 
serum  withdrawal,  cells  were  incubated  with  20  ng/ml  LPA  for 
RhoA  activation,  10  ng/ml  PDGF  for  Rac1  activation,  or  100 
ng/ml  Bradykinin  for  Cdc42  activation.  Cells  were  stained  with 
anti-HA  and  rhodamine-conjugated  phalloidin  to  visualize  HA- 
RhoGAP68F  (green)  and  filamentous  actin  (red),  respectively. 
Scale  bar,  20  μm.
specific  effects  on  the  organization  of  the  actin 
cytoskeleton  in  fibroblasts:  RhoA  produces  stress 
fibers  associated  with  focal  adhesion  complexes, 
Rac1  induces  lamellipodia  and  membrane  ruffles, 
and  Cdc42  triggers  the  formation  of  filopodia  or 
microspikes (Hall, 1998). To further characterize the 
substrate  specificity  of  RhoGAP68F,  we  examined 
the  effect  of  RhoGAP68F  overexpression  on  the 
actin  cytoskeleton  in  cultured  cells.  NIH3T3  cells 
were  transfected  with  HA-tagged  RhoGAP68F  and 
then  stained  with  rhodamine-conjugated  phalloidin 
to  visualize  actin  filaments.  As  shown  in  Fig.  3, 
expression  of  RhoGAP68F  inhibited  lysophosphatidic 
acid  (LPA)-induced  stress  fiber  formation  mediated 
by RhoA (Fig. 3A). However, RhoGAP68F expression 
had  no  effect  on  either  PDGF-induced  membrane 
ruffling mediated by Rac1 or Bradykinin-induced filo-
podia  formation  mediated  by  Cdc42.  Finally,  LPA- 
induced  stress  fiber  formation  was  not  significantly 
affected  by  expression  of  the  R315A  GAP-deficient 
mutant  (Fig.  3B).  These  results  suggest  that 
RhoGAP68F  acts  as  a  RhoA-selective  GAP  in 
NIH3T3  cells.
Neuronal overexpression of RhoGAP68F induces 
synaptic  overgrowth  at  the  Drosophila  larval 
neuromuscular  junction
    Because  RhoGAP68F  was  found  highly  in  the 
embryonic CNS, we wished to determine the role of 
RhoGAP68F in synapse development. To investigate 
this,  we  expressed  exogenous  RhoGAP68F  in  all RhoGAP68F  is  a  Neuronal  GAP  for  RhoA 33
Fig. 4. Neuronal overexpression of RhoGAP68F causes synaptic 
overgrowth  at  the  larval  NMJ.  (A,  B)  Confocal  images  of  third 
instar  NMJs  6/7  labeled  with  anti-HRP  are  shown  for  Elav-GS- 
GAL4/＋ and  Elav-GS-GAL4/UAS-RhoGAP68F  larvae.  Note  that 
presynaptic  overexpression  of  RhoGAP68F  causes  NMJ  over-
growth.  Scale  bar,  50  μm.    (C)  Quantification  of  total  bouton 
n u m b e r  a n d  b r a n c h  n u m b e r  a t  N M J s  6 / 7  i n  Elav-GS-GAL4/＋
and Elav-GS-GAL4/UAS-RhoGAP68F third instar larvae. Data are 
mean±SEM. The numbers of NMJs analyzed are indicated inside 
bars.  Statistically  significant  differences  are  indicated  by  asterisk 
(p＜0.001). 
neurons  and  then  examined  synaptic  growth  at  the 
larval neuromuscular junction (NMJ). Overexpression 
of  RhoGAPs  at  embryonic  stages  could  cause 
defects  in  axon  development  (Billuart  et  al.,  2001), 
complicating  analysis  of  its  effect  on  synaptic 
growth.  Therefore,  we  overexpressed  UAS-RhoGAP68F 
in all neurons from the early first instar stage, when 
synapse formation between motor axons and target 
muscles  is  already  finished,  by  employing  the 
inducible neuronal GAL4 driver Elav-GS-GAL4 system, 
in  which  gene  expression  is  induced  only  by  the 
addition  of  the  progesterone  analog  RU486  (Oster-
walder  et  al.,  2001).  When  raised  on  the  food 
containing  RU486  throughout  larval  development, 
third  instar  Elav-GS-GAL4/UAS-RhoGAP68F  animals 
displayed  excessive  NMJ  growth  (Fig.  4A,  B).  To 
quantify this phenotype, we measured bouton number 
and  branch  number  at  NMJ  6/7  in  abdominal 
segment 2 (Fig. 4C). Bouton number was increased 
by 42% in Elav- GS-GAL4/UAS-RhoGAP68F larvae 
compared  with  Elav-GS-GAL4/＋  controls  (169.4±5.3 
versus 120.0±2.1;  mean±SEM; p<0.001). In addition, 
the  number  of  NMJ  branches  was  increased  by 
86% (29.7±0.8 versus 16.0±0.7; p＜0.001), supporting 
a  novel  role  for  RhoGAP68F  in  the  regulation  of 
synaptic  growth.
    In summary, we provide evidence that RhoGAP68F 
functions as a negative regulator of RhoA signaling 
in  vivo.  This  conclusion  is  consistent  with  a  pre-
vious  finding  that  RhoGAP68F  acts  as  a  RhoA- 
selective GAP in vitro (Sanny et al., 2006). Although 
RhoGAP68F  is  shown  to  regulate  morphogenetic 
events  during  gastrulation  of  the  embryo  (Sanny  et 
al.,  2006),  it  has  not  been  addressed  whether  they 
also  regulates  neuronal  morphogenesis.  In  this 
study,  we  have  shown  that  RhoGAP68F  is  highly 
expressed  in  the  nervous  system  and  that  pre-
synaptic overexpression of RhoGAP68F affects NMJ 
growth,  raising  the  possibility  that  RhoA  signaling 
and  its  regulators  may  play  a  key  role  in  synaptic 
growth  and  plasticity  during  development. 
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